Journal of Dermatological Treatment · 2010 · 56 citations · 6 references
MedicineDermatologyPathologyDermatopathologyNeoplasiaNeuropathologyCutaneous NeoplasmsInflammatory DermatosesInflammatory Skin DiseasesNeurocutaneous SyndromesTuberous Sclerosis ComplexVascular Skin LesionsMammalian Target Of Rapamycin Signaling
Tuberous sclerosis complex (TSC) is an autosomal dominant neurocutaneous syndrome manifesting as hamartomatous growths in multiple organs. We present two cases of patients with TSC and associated facial angiofibromata treated with topical and oral rapamycin and discuss the role for rapamycin in the treatment of these disfiguring lesions. Our patients demonstrated decreased numbers of angiofibromata and less redness with this treatment. This is the first published report on the use of topical rapamycin for the treatment of angiofibromata.
6
Rapamycin causes regression of astrocytomas in tuberous sclerosis complex
David Neal Franz, Jennifer Leonard, Cynthia Tudor et al. · Annals of Neurology · 2006 · 615 citations
Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model
Aubrey Rauktys, Nancy Y. Lee, Laifong Lee et al. · BMC Dermatology · 2008 · 48 citations · Full text
Medicine, Oncology, Pharmacology +16